
ALT5 Sigma Corporation (ALTS) is a dynamic fintech and biotech firm, aiming to revolutionize digital assets and health care. It offers blockchain-powered platforms like ALT5 Prime, an over-the-counter trading system for digital assets, and ALT5 Pay, a crypto payment gateway for seamless merchant transactions. In biotech, it develops non-opioid therapies, such as JAN101 for pain relief in arterial disease and JAN123 for chronic pain syndromes.
Founded in 1976 and originally named JanOne until 2024, the company is headquartered in Las Vegas, Nevada, with operations and clients across North America, Europe, and beyond.